DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 49 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2015. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$3,170,000
-68.6%
1,315,5510.0%0.14%
-67.0%
Q4 2015$10,090,000
+45.0%
1,315,5510.0%0.41%
+52.0%
Q3 2015$6,959,000
-41.0%
1,315,5510.0%0.27%
-31.6%
Q2 2015$11,800,000
+36.8%
1,315,551
-3.6%
0.39%
+40.9%
Q1 2015$8,627,000
+239.0%
1,365,000
+458.2%
0.28%
+168.3%
Q1 2014$2,545,000244,5240.10%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders